Clinical Trials in San Francisco

Showing 2921-2940 of 6,211 trials

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

NCT02462603

Open-label study with 30-day run-in phase and adaptive design component to include more participants if deemed appropriate by investigators.

Parkinson's Disease

Edison Pharmaceuticals Inc44 participantsStarted May 2016

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDNA< 1 mile

VL-3 Training Study

NCT05356754

The primary endpoints for this study are mean and standard deviation error measurements for the VLDBPM versus manual auscultation.

HypertensionBlood Pressure

Riva Health343 participantsStarted Jul 2020

San Francisco, California, United States • Walnut Creek, California, United States • Aurora, Colorado, United States

COMPLETEDNA10 miles

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment

NCT04206670

This study aims to develop and evaluate new in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment.

DementiaMild Cognitive ImpairmentAlzheimer Disease

University of California, Berkeley216 participantsStarted Mar 2020

Berkeley, California, United States

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

VL-3 Training Study

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment

Find Trials by Condition in San Francisco

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

rTMS for Orthopaedic Trauma Patients

The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)

Study of XL647 Administered Orally Daily to Patients With Solid Tumors

Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors

Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD

Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Physician Reimbursement Home Patients

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity